Paper22246830
Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China.
Shen L and 6 others. J Med Virol, 2012. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China. Papers, record 22246830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22246830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enzyme-Linked Immunosorbent Assay | Major topic |
| Hepatitis Antibodies | Major topic |
| Hepatitis B | Major topic |
| Hepatitis D | Major topic |
| Hepatitis Delta Virus | Major topic |
| China | |
| Coinfection | |
| Hepatitis B virus | |
| Hepatitis delta Antigens | |
| Humans | |
| Prevalence |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40461976 | Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses. | Biol Proced Online | 2025 | https://conductscience.org/library/papers/40461976 | PubMed |
| 36727249 | [Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region]. | Zhonghua Gan Zang Bing Za Zhi | 2022 | https://conductscience.org/library/papers/36727249 | PubMed |
| 36727224 | [The epidemiology and screening of hepatitis D]. | Zhonghua Gan Zang Bing Za Zhi | 2022 | https://conductscience.org/library/papers/36727224 | PubMed |
| 35905419 | Digital Droplet PCR for Detection and Quantitation of Hepatitis Delta Virus. | Clin Transl Gastroenterol | 2022 | https://conductscience.org/library/papers/35905419 | PubMed |
| 34578380 | HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection. | Viruses | 2021 | https://conductscience.org/library/papers/34578380 | PubMed |
| 28677645 | Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen. | Viruses | 2017 | https://conductscience.org/library/papers/28677645 | PubMed |
| 27280621 | Comparison of Enzyme Immunoassays for Detection of Antibodies to Hepatitis D Virus in Serum. | Clin Vaccine Immunol | 2016 | https://conductscience.org/library/papers/27280621 | PubMed |
| 27166628 | Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China. | Clin Drug Investig | 2016 | https://conductscience.org/library/papers/27166628 | PubMed |
| 25532128 | Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China. | PLoS One | 2014 | https://conductscience.org/library/papers/25532128 | PubMed |
| 25313681 | The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology. | PLoS One | 2014 | https://conductscience.org/library/papers/25313681 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22246830
GET https://conductscience.org/api/papers/v1/22246830/authors